Freeport-Mcmoran Inc: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Nov 6, 2020 and accepted by EDGAR at Nov 6, 2020, 11:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $3.74bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $9.65bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-07-01 to 2020-09-30 | $2.87bn | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-01-01 to 2020-09-30 | $8.59bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2020-07-01 to 2020-09-30 | $72.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-09-30 | $273.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-07-01 to 2020-09-30 | $880.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-30 | $728.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $297.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | $333.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | $432.0m | us-gaap:ProfitLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | $7.0m | us-gaap:ProfitLoss |
| Basic EPS | 3 months2020-07-01 to 2020-09-30 | $0.22 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-30 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-01 to 2020-09-30 | 1,461,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-30 | 1,453,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $1.69bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-07-01 to 2020-09-30 | $436.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $1.57bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2020-01-01 to 2020-09-30 | $73.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2020-09-30 | $2.40bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-30 | $8.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $41.10bn | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $3.10bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-09-30 | $23.54bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-09-30 | $9.98bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-09-30 | $47.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-09-30 | $9.24bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000831259-20-000040. Last ingested by Listed: Nov 6, 2026, 13:42 ET. Listed shows no prices and gives no investment advice.